Home > Healthcare > Medical Devices > Therapeutic Devices > Stroke Management Market

Stroke Management Market Size

Report ID: GMI3550
Published Date: Nov 2022
Report Format: PDF

Download Free Sample

Stroke Management Market Size

Stroke Management Market size was valued at over USD 37 billion in 2022. Driven by the increasing instances of cardiovascular ailments, the market is poised to grow at 6% CAGR from 2023 to 2032.

Stroke Management Market

To get key market trends

Download Free Sample

Rising cases of cardiovascular diseases (CVDs) across the globe are fuelling the industry outlook. As per CDC, in 2020, nearly 697,000 people died from cardiac disease in the U.S., accounting for 1 in every 5 deaths. Meanwhile, the WHO estimates that CVDs lead to approximately 17.9 million deaths yearly, accounting for nearly 31% of mortalities globally. Cardiac ailments increase the risks of stroke and coronary artery disease, often leading to mortalities or other health complications that lead to disabilities, creating a notable demand for effective stroke management products and services.

Stroke Management Market Report Attributes
Report Attribute	Details
Base Year:	2022
Stroke Management Market Size in 2022:	USD 37,237.2 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6.0%
2032 Value Projection:	USD 59,952.4 Million
Historical Data for:	2018 to 2022
No. of Pages:	280
Tables, Charts & Figures:	381
Segments covered:	Type, Product, End-use, and Region
Growth Drivers:	Growing preference for minimally invasive procedures Increasing prevalence of cardiovascular diseases worldwide Technological advancement in stroke management Rising geriatric population in developing economies
Pitfalls & Challenges:	Stringent regulatory framework High cost of procedures

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for stroke management held a valuation of over USD 37 billion in 2022 and is poised to grow at 6% CAGR between 2023 and 2032.

APAC market for stroke management is poised to surpass USD 17 billion by 2032, driven by rising public and private sector spending on generating awareness about cardiovascular disorders and the rising market player focus on emerging Asia-Pacific countries.

The transient ischemic attack (TIA) segment is expected to cross USD 1.5 billion by 2032, fueled by escalating the adoption of stroke management devices and growing preference for catheter-based devices for interventional procedures.

Some of the leading market players include Asahi Intecc CO., LTD, GE Healthcare, Abbott, Johnson & Johnson, Medtronic, Boston Scientific Corporation, Penumbra, Inc., among others.